A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma's Annual Report 2014 published

Herantis Pharma's Annual Report 2014 published Herantis Pharma Plc Company release 24 March 2015 at 10:00 am Herantis Pharma Plc's…

Read More

Herantis Pharma announces an internationally renowned Scientific Advisory Board with Professor Jonathan Knowles as Chairman

Herantis Pharma announces an internationally renowned Scientific Advisory Board with Professor Jonathan Knowles as Chairman Herantis Pharma Plc Company release…

Read More

Herantis Pharma's Phase 2 Dry Eye study recruitment completed ahead of schedule

Herantis Pharma's Phase 2 Dry Eye study recruitment completed ahead of schedule Herantis Pharma Plc Company release 11 March 2015…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.